SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Northwest Biotherapeutics NWBT -- Ignore unavailable to you. Want to Upgrade?


To: Jack Hartmann who wrote (1)4/2/2002 3:45:20 PM
From: Jack Hartmann  Respond to of 2
 
Insiders for 2002.
2002-02-21 -
2002-02-25 WILDS, DANIEL O.
President 6,300 Purchase at $3.10 - $3.78 per share.
(Cost of about $22,000)
2002-02-21 RAGDE, HAAKON
Director 2,000 Purchase at $3.79 - $3.8 per share.
(Cost of about $7,590)
2002-02-11 -
2002-02-22 BOYNTON, ALTON L.
Executive Vice President 5,550 Purchase at $3.46 - $4 per share.
(Cost of about $21,000)
2002-02-08 -
2002-02-27 CAUDILL, RANDALL L.W.
Director 4,200 Purchase at $3 - $4.68 per share.
2002-01-25 WILDS, DANIEL O.
President 2,500 Purchase at $4.46 per share.
(Cost of $11,150)
2002-01-17 CAUDILL, RANDALL L.W.
Director 500 Purchase at $4.56 per share.
(Cost of $2,280)
2002-01-11 SALGALLER, MICHAEL
Officer 235 Purchase at $4.40 per share.
(Cost of $1,034)
2002-01-02 -
2002-01-10 NORTHWEST HOSPITAL
Beneficial Owner (10% or more) 225,000 Sale at $5 per share.
(Proceeds of $1,125,000)
2002-01-02 -
2002-01-10 SCHNEIDER, C. WILLIAM
Director *225,000 Sale at $5 per share.
(Proceeds of $1,125,000)
2002-01-01 -
2002-01-31 HOLMES, ERIC
Officer 10,622 Option Exercise at $0.50 - $1.25 per share

Jack